Guggenheim Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD)
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $80.00 price target on the stock. Guggenheim’s target price points to a potential upside of 113.45% from the stock’s current price. Several other […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $80.00 price target on the stock. Guggenheim’s target price points to a potential upside of 113.45% from the stock’s current price. Several other […]
